Back to Search Start Over

Circulating metabolites are associated with brain atrophy and white matter hyperintensities.

Authors :
de Leeuw FA
Karamujić-Čomić H
Tijms BM
Peeters CFW
Kester MI
Scheltens P
Ahmad S
Vojinovic D
Adams HHH
Hankemeier T
Bos D
van der Lugt A
Vernooij MW
Ikram MA
Amin N
Barkhof F
Teunissen CE
van Duijn CM
van der Flier WM
Source :
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2021 Feb; Vol. 17 (2), pp. 205-214. Date of Electronic Publication: 2020 Sep 04.
Publication Year :
2021

Abstract

Introduction: Our aim was to study whether systemic metabolites are associated with magnetic resonance imaging (MRI) measures of brain and hippocampal atrophy and white matter hyperintensities (WMH).<br />Methods: We studied associations of 143 plasma-based metabolites with MRI measures of brain and hippocampal atrophy and WMH in three independent cohorts (n = 3962). We meta-analyzed the results of linear regression analyses to determine the association of metabolites with MRI measures.<br />Results: Higher glucose levels and lower levels of three small high density lipoprotein (HDL) particles were associated with brain atrophy. Higher glucose levels were associated with WMH.<br />Discussion: Glucose levels were associated with brain atrophy and WMH, and small HDL particle levels were associated with brain atrophy. Circulating metabolites may aid in developing future intervention trials.<br /> (© 2020 The Authors. Alzheimer's & Dementia published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.)

Details

Language :
English
ISSN :
1552-5279
Volume :
17
Issue :
2
Database :
MEDLINE
Journal :
Alzheimer's & dementia : the journal of the Alzheimer's Association
Publication Type :
Academic Journal
Accession number :
32886448
Full Text :
https://doi.org/10.1002/alz.12180